Frontiers of Medicine

, Volume 12, Issue 5, pp 580–585 | Cite as

Sensitivity of supplementation of thyroid hormone on treatment of idiopathic short-stature children during therapy with recombinant human growth hormone

  • Wei WangEmail author
  • Shuqin Jiang
  • Zhirui Cui
  • Xiangyang Luo
  • Lingli Shi
  • Heli Zheng
Letter to Frontiers of Medicine


This study aimed to evaluate the effects of thyroid hormone supplementation on growth rate of children with idiopathic short stature (ISS) and low-normal serum free thyroxine FT4 who were receiving growth hormone therapy. We selected 64 prepubertal children with FT4 levels in the lowest third of the normal range as the lower FT4 group, and these children were divided randomly into two subgroups: L-thyroxine (L-T4)-treated subgroup was treated with L-T4 (0.5–3.0 g/(kg·d)) from the beginning of the study, and the non-L-T4-treated subgroup received placebo. We also selected 39 ISS children with FT4 in the upper two-thirds of the normal range as the higher FT4 group. During the first year, the lower FT4 group featured lower FT3, FT4, thyroid stimulating hormone (TSH), and insulin-like growth factor-I standard deviation score (IGF-I SDS) and significantly lower height velocity (HV) compared with the higher FT4 group. However, in the lower FT4 group, the L-T4-treated subgroup presented higher FT4, FT3, TSH, and IGF-I SDS concentrations and significantly higher HV compared with children in the non-L-T4-treated subgroup. In children with ISS, the negative effect of thyroid hormone deficiency on growth rate should be considered when FT4 level lies in the low-normal range prior to recombinant human growth hormone treatment.


therapeutic idiopathic short-stature children free T4 the first year recombinant human growth hormone 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jørgensen JO, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE, Christiansen JS. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J Clin Endocrinol Metab 1989; 69(6): 1127–1132CrossRefGoogle Scholar
  2. 2.
    Jørgensen JO, Møller J, Skakkebaek NE, Weeke J, Christiansen JS. Thyroid function during growth hormone therapy. Horm Res 1992; 38(Suppl 1): 63–67CrossRefGoogle Scholar
  3. 3.
    Martins MR, Doin FC, Komatsu WR, Barros-Neto TL, Moises VA, Abucham J. Growth hormone replacement improves thyroxine biological effects: implications for management of central hypothyroidism. J Clin Endocrinol Metab 2007; 92(11): 4144–4153CrossRefGoogle Scholar
  4. 4.
    Saggese G, Cesaretti G, Di Spigno G, Cinquanta L, Giannessi N, Cioni C, Bracaloni C. Thyroid and thyrotropin functions in subjects with pituitary nanism treated with growth hormone. Pediatr Med Chir 1990; 12(5): 483–488 (in Italian)Google Scholar
  5. 5.
    Pirazzoli P, Cacciari E, Mandini M, Sganga T, Capelli M, Cicognani A, Gualandi S. Growth and thyroid function in children treated with growth hormone. J Pediatr 1992; 121(2): 210–213CrossRefGoogle Scholar
  6. 6.
    Wyatt DT, Gesundheit N, Sherman B. Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients: lack of need for thyroxine supplementation. J Clin Endocrinol Metab 1998; 83(10): 3493–3497Google Scholar
  7. 7.
    Portes ES, Oliveira JH, MacCagnan P, Abucham J. Changes in serum thyroid hormones levels and their mechanisms during longterm growth hormone (GH) replacement therapy in GH deficient children. Clin Endocrinol (Oxf) 2000; 53(2): 183–189CrossRefGoogle Scholar
  8. 8.
    Kalina-Faska B, Kalina M, Koehler B. Assessment of thyrotropin concentrations in children with somatotropin deficiency treated with growth hormone. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2002; 8(1): 17–21 (in Polish)Google Scholar
  9. 9.
    Giavoli C, Porretti S, Ferrante E, Cappiello V, Ronchi CL, Travaglini P, Epaminonda P, Arosio M, Beck-Peccoz P. Recombinant hGH replacement therapy and the hypothalamus-pituitarythyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism? Clin Endocrinol (Oxf) 2003; 59(6): 806–810CrossRefGoogle Scholar
  10. 10.
    Kalina-Faska B, Kalina M, Koehler B. Effects of recombinant growth hormone therapy on thyroid hormone concentrations. Int J Clin Pharmacol Ther 2004; 42(1): 30–34CrossRefGoogle Scholar
  11. 11.
    Seminara S, Stagi S, Candura L, Scrivano M, Lenzi L, Nanni L, Pagliai F, Chiarelli F. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catchup growth? Horm Metab Res 2005; 37(12): 751–756CrossRefGoogle Scholar
  12. 12.
    Susperreguy S, Muñoz L, Tkalenko NY, Mascanfroni ID, Alamino VA, Montesinos MM, Masini-Repiso AM, Miras MB, Pellizas CG. Growth hormone treatment in children with idiopathic short stature: correlation of growth response with peripheral thyroid hormone action. Clin Endocrinol (Oxf) 2011; 74(3): 346–353CrossRefGoogle Scholar
  13. 13.
    Rose SR. Isolated central hypothyroidism in short stature. Pediatr Res 1995; 38(6): 967–973CrossRefGoogle Scholar
  14. 14.
    García RJ, Iñiguez G, Gaete X, Linares J, Ocaranza P, Avila A, Roman R, Cassorla F. Effects of levothyroxine on growth hormone (GH) sensitivity in children with idiopathic short stature. Growth Horm IGF Res 2014; 24(4): 119–122CrossRefGoogle Scholar
  15. 15.
    Ismail NA, Metwaly NS, El-Moguy FA, Hafez MH, El Dayem SM, Farid TM. Growth response of Egyptian children with idiopathic short stature during four years of growth hormone therapy. Indian J Hum Genet 2011; 17(3): 218–225CrossRefGoogle Scholar
  16. 16.
    Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res 2008; 18(2): 89–110CrossRefGoogle Scholar
  17. 17.
    Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM; 2007 ISS Consensus Workshop participants. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2008; 93(11): 4210–4217CrossRefGoogle Scholar
  18. 18.
    Agha A, Walker D, Perry L, Drake WM, Chew SL, Jenkins PJ, Grossman AB, Monson JP. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol (Oxf) 2007; 66(1): 72–77Google Scholar
  19. 19.
    Ocaranza P, Lammoglia JJ, Iñiguez G, Román R, Cassorla F. Effects of thyroid hormone on the GH signal transduction pathway. Growth Horm IGF Res 2014; 24(1): 42–46CrossRefGoogle Scholar
  20. 20.
    Smyczynska J, Stawerska R, Lewinski A, Hilczer M. Do IGF-I concentrations better reflect growth hormone (GH) action in children with short stature than the results of GH stimulating tests? Evidence from the simultaneous assessment of thyroid function. Thyroid Res 2011; 4(1): 6–13CrossRefGoogle Scholar
  21. 21.
    Xing W, Govoni KE, Donahue LR, Kesavan C,Wergedal J, Long C, Bassett JH, Wojcicka A, Williams GR, Mohan S. Genetic evidence that thyroid hormone is indispensable for prepubertal IGF-I expression and bone acquisition in mice. J Bone Miner Res 2012; 27: 1067–1079CrossRefGoogle Scholar
  22. 22.
    Berglund A, Gravholt CH, Olsen MS, Christiansen JS, Stochholm K. Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency. Clin Endocrinol (Oxf) 2015; 83(5): 677–683CrossRefGoogle Scholar
  23. 23.
    Inukai T, Takanashi K, Takebayashi K, Fujiwara Y, Tayama K, Takemura Y. Thyroid hormone modulates insulin-like growth factor-I (IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases. Horm Metab Res 1999; 31(10): 576–579CrossRefGoogle Scholar
  24. 24.
    Zayed S, Madlon-Kay DJ. Growth hormone for treatment of idiopathic short stature in children. Am Fam Physician 2015; 92(1): 64Google Scholar
  25. 25.
    Ramos S, Goya L, Alvarez C, Martín MA, Pascual-Leone AM. Effect of thyroxine administration on the IGF/IGF binding protein system in neonatal and adult thyroidectomized rats. J Endocrinol 2001; 169(1): 111–122CrossRefGoogle Scholar
  26. 26.
    Catli G, Abaci A, Büyükgebiz A, Bober E. Subclinical hypothyroidism in childhood and adolescense. J Pediatr Endocrinol Metab 2014; 27(11-12): 1049–1057Google Scholar
  27. 27.
    De Luca F, Corica D, Pitrolo E, Santucci S, Romeo M. Idiopathic and mild subclinical hypothyroidism in childhood: clinical management. Minerva Pediatr 2014; 66(1): 63–68Google Scholar
  28. 28.
    Cetinkaya E, Aslan A, Vidinlisan S, Ocal G. Height improvement by L-thyroxine treatment in subclinical hypothyroidism. Pediatr Int 2003; 45(5): 534–537CrossRefGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Wei Wang
    • 1
    • 2
    Email author
  • Shuqin Jiang
    • 2
  • Zhirui Cui
    • 2
  • Xiangyang Luo
    • 2
  • Lingli Shi
    • 2
  • Heli Zheng
    • 2
  1. 1.Pediatric Endocrinology ClinicThird Affiliated Hospital of Zhengzhou UniversityZhengzhouChina
  2. 2.Third Affiliated Hospital of Zhengzhou UniversityZhengzhouChina

Personalised recommendations